LYMTAC-2
Product Specifications
Target
Ras, Kras, Others
Related Pathways
MAPK, Others
Bioactivity
LYMTAC-2 is a lysosome-targeting chimera (LYMTAC) developed to degrade membrane-associated proteins through lysosomal membrane proteins (LMP) such as RNF152, LAPTM4a, and LAPTM5. It forms a ternary complex with target proteins like KRASG12D, facilitating their relocation to lysosomes and resulting in ubiquitin-dependent degradation. This compound has potential for studying membrane protein regulation and devising strategies to counter resistance in KRAS-driven signaling pathways.
Molecular Weight
1248.44
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15395646 1 Vial
Lentiviral human ZNF551 sgRNA gene knockout kit - Lentiviral human ZNF551 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details 
F4305-08J-AP 200 µL
FGFR1 (Y653) (Basic Fibroblast Growth Factor Receptor 1, FGFR-1, bFGF-R, Proto-oncogene c-Fgr, Fms-like Tyrosine Kinase 2, FLT-2, CD331, FGFBR, FLG, FLT2) (AP) discontinued
Sign In for Pricing
View Details A00875-4-Fluoro488 100 µg/Vial
Anti-DLL4 Antibody Picoband® Fluoro488 Conjugated
Sign In for Pricing
View Details